MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202311074593 A) filed by Akums Drugs & Pharmaceuticals Limited, New Delhi, on Nov. 1, 2023, for 'an oral formulation comprising sitagliptin, voglibose and metformin.'
Inventor(s) include Jain Sanjeev.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "The present invention related to a pharmaceutical composition comprising fixed dose combinations of Type 2 diabetes therapeutic agents more particularly to oral formulation comprising fixed dose combinations of Sitagliptin, Voglibose and Metformin. The oral formulation is a bi-layer tablet formulation com...